{"id":5670,"date":"2019-06-17T11:50:46","date_gmt":"2019-06-17T09:50:46","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/uncategorized\/10-biotech-presse-lounge-am-21-februar-2019\/"},"modified":"2020-07-13T14:50:29","modified_gmt":"2020-07-13T12:50:29","slug":"10-biotech-presse-lounge-am-21-februar-2019","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/10-biotech-presse-lounge-am-21-februar-2019\/","title":{"rendered":"10th Biotech Press Lounge on \u00ad the 21st of February 2019"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

10th Biotech Press Lounge on \u00adthe 21st of February 2019<\/span><\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine-lead”]Network meeting with key players in the biotech branche
\n[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]June 2019[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”two-columns”][vc_column_inner][vc_single_image image=”5666″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription” el_id=”special-high”]Dr. Peter Hanns Zobel<\/strong>, Managing Director, IZB, Eva M\u00fcller<\/strong>, Journalist, Manager Magazin, \u00adDr. Ali Ert\u00fcrk<\/strong>, Director of the new Institute of Tissue Engineering and Regenerative Medicine (iTERM) at Helmholtz Center Munich, Dr. Hubert Birner<\/strong>, Managing Partner, TVM Capital GmbH, Phil L’Huillier<\/strong>, Ph.D., Head of Business Development, Europe & Middle East, MSD Innovation Hub (v.l.n.r.)[\/vc_column_text][vc_single_image image=”5664″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription” el_id=”special-high”]Dr. Hubert Birner<\/strong>, Managing Partner, TVM Capital GmbH,
\nEva M\u00fcller<\/strong>, Journalist, Manager Magazin (v.l.n.r.)[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]TVM Capital, MSD and Dr. Ali Ert\u00fcrk talk about the VC-market, pharmaceutical cooperations and new technologies<\/strong><\/p>\n

\u201cWe are pleased that industry leaders and high-profile scientists are presenting strategies of the venture capital and pharmaceutical business, or pioneering research results at the Biotech Press Lounge, and that multipliers are regularly using the event to network,\u201d said Dr. Peter Hanns Zobel, Managing Director of the IZB, at the beginning of the 10th Biotech Press Lounge on February 21, 2019.<\/p>\n

Dr. Ing. Hubert Birner, Managing Partner of TVM Capital GmbH and Phil L’Huillier, Ph.D., Head of Business Development Europe & Middle East MSD Innovation Hub, gave interesting keynote speeches before the 100 guests. Dr. Ali Ert\u00fcrk, at that time a group leader at the Institue for Stroke and Dementia Research of the University Munich (now Helmholtz Center), presented a technology to produce 3D bio-printed organs within five years.
\n[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote”][vc_column_inner][vc_column_text]<\/p>\n

\u201cMSD has also recently opened a new Discovery Research Center in London. Excellent scientific minds are working there on the challenges and sufferings of an ageing society.\u201d<\/h6>\n

Phil L\u00b4Huillier, Ph.D., Head of Business Development,
\nEurope & Middle East, MSD Innovations Hub<\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]The journalist Eva M\u00fcller from Manager Magazine moderated the event with 100 guests from biotech, pharmaceutical and venture capital companies as well as top researchers from the Martinsried Campus in the Faculty Club G2B (Gateway to Biotech). She first announced Dr. Hubert Birner, a veteran of the venture capital scene. In his presentation titled \u201cSleepless Nights in 2019 for a Venture Capitalist,\u201d he first illuminated the financing business in 2018 in German-speaking countries, highlighted the fundraising environment for biotech companies and investors, and looked at possible deals in 2019. Phil L’Huillier, Ph.D., talked about \u201cCollaboration Opportunities with MSD and the New Discovery Research Center in London\u201d. In his keynote address, \u201cTransformative Technologies to Accelerate Biomedical Research and Treat Fatal Diseases in Our Lives,\u201d Dr. Ali Ert\u00fcrk presented his new imaging technologies, a combination of artificial intelligence, nanotechnology, and Engineering.<\/p>\n

[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”two-columns” css=”.vc_custom_1594644625541{margin-bottom: 20px !important;}”][vc_column_inner][vc_single_image image=”5668″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription” el_id=”special-high”]Phil L’Huillier<\/strong>, Ph.D., Head of Business Development, Europe & Middle East, MSD Innovation Hub[\/vc_column_text][vc_single_image image=”5662″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription” el_id=”special-high”]Dr. Ali Ert\u00fcrk<\/strong>, Director of the new Institute of Tissue Engineering and Regenerative Medicine (iTERM) at Helmholtz Center Munich[\/vc_column_text][\/vc_column_inner][\/vc_row_inner]\n\n

\n \n